Abstract
Aims:
To study the efficacy of verteporfin photodynamic therapy (VPDT) retrospectively in the treatment of idiopathic subfoveal choroidal neovascularization (ICNV) in an Asian population in correlation with number of treatments and age at treatment. This is the first report to compare the efficacy between single and multiple treatments.
Methods:
VPDT was administered according to protocol to 45 eyes in 45 patients aged 18–55 years diagnosed with active subfoveal ICNV between September 2003 and December 2005. In total 28 patients received a single VPDT treatment and the remaining 17 received multiple treatments. Collected measurements of visual acuity (VA) were plotted on a time-course model, and later dichotomized by age (18–45 vs46–55 years).
Results:
The 28 patients receiving a single VPDT treatment showed significant improvement in VA at 3-month follow-up. The 17 patients, who did not show improvement after the first treatment, received multiple VPDT treatments. Those patients showed an even clearer trend in VA improvement although significance was detected only at the 24th month. All patients showed a significant improvement in mean VA of 0.46 logMAR (P<0.01 compared to baseline) by the end of the 24-month observation period, although VPDT treatment for subfoveal ICNV appears to stabilize vision more rapidly in younger patients.
Conclusions:
ICNV patients who did not benefit from single VPDT treatments could receive multiple treatments, and showed a more significant improvement in visual acuity. These results are the first of their kind in ICNV treatment.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Fukuchi T, Takahashi K, Ida H, Sho K, Matsumura M . Staging of idiopathic choroidal neovascularization by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2001; 239: 424–429.
Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ . Etiology of choroidal neovascularization in young patients. Ophthalmology 1996; 103: 1241–1244.
Giansanti F, Virgili G, Varano M, Tedeschi M, Rapizzi E, Giacomelli G et al. Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina 2005; 25: 590–596.
Chan WM, Lam DS, Wong TH, Lai TY, Kwok AK, Tam BS et al. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series. Ophthalmology 2003; 110: 2395–2402.
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Arch Ophthalmol 1999; 117: 1329–1345.
Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993; 111: 1200–1209.
Verteporfin Roundtable Participants. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 2005; 25: 119–134.
Stone TW, Sternberg Jr P . Submacular surgery trials update. Ophthalmol Clin North Am 2002; 15: 479–488.
Ruiz-Moreno JM, Montero JA, Arias L, Sanabria MR, Coco R, Silva R et al. Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization. Acta Ophthalmol Scand 2006; 84: 743–748.
Kumar A, Prakas G, Singh RP . Transpupillary thermotherapy for idiopathic subfoveal choroidal neovascularization. Acta Ophthalmol Scand 2004; 82: 205–208.
Yoo MH, Boo HD, Kim HK . Result of photodynamic therapy for idiopathic subfoveal choroidal neovascularization. Korean J Ophthalmol 2005; 19: 264–268.
TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: 2-year results of 2 randomized clinical trials—TAP report 2. Arch Ophthalmol 2001; 119: 198–207.
Lam A, Lee HC, Ho AC, Regillo CD, McNamara JA, Fineman MD . Photodynamic therapy in young patients. Ophthalmic Surg Lasers Imaging 2006; 37: 182–189.
Fenton C, Perry CM . Verteporfin: a review of its use in the management of subfoveal choroidal neovascularisation. Drugs Aging 2006; 23: 421–445.
Chan WM, Lai TY, Tano Y, Liu DT, Li KK, Lam DS . Photodynamic therapy of macular diseases of Asian populations: when East meets West. Jpn J Ophthalmol 2006; 50: 161–169.
Maár N, Ergun E, Luksch A, Stur M . Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1262–1266.
Chen YS, Lin JY, Tseng SY, Yow SG, Hsu WJ, Tsai SC . Photodynamic therapy for Taiwanese patients with pathologic myopia: a 2-year follow-up. Retina 2007; 27 (7): 839–845.
Capone Jr A, Wallace RT, Meredith TA . Symptomatic choroidal neovascularization in blacks. Arch Ophthalmol 1994; 112: 1091–1097.
Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 2003; 110 (5): 979–986.
Ergun E, Heinzl H, Stur M . Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol 2004; 138: 434–438.
Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y et al. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment. Am J Ophthalmol 2004; 138: 602–607.
Ho AC, Yannuzzi LA, Pisicano K, DeRosa J . The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology 1995; 102: 782–789.
Rogers AH, Duker JS, Nichols N, Baker BJ . Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 2003; 110: 1315–1320.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, YS., Lin, JS., Tseng, SY. et al. Photodynamic therapy of idiopathic subfoveal choroidal neovascularization in Taiwanese patients: a 2-year follow-up. Eye 23, 314–319 (2009). https://doi.org/10.1038/sj.eye.6703073
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6703073
